摘要:
It is an objective of the present invention to provide a non-invasive transdermal immunizing technology by which inflammation and lump do not appear at the skin unlike conventional transdermal immunizing methods with subcutaneous administration and the development amount of antibody in serum is increased. The S/O type transdermal immunizing agent according to the present invention comprises an antigen-surfactant complex and an oil phase; wherein the antigen is covered with the surfactant in the complex; the complex is in a solid state; and the complex is dissolved or dispersed in the oil phase.
摘要:
The present invention provides an external preparation which can improve a skin permeability of a hydrophilic medicine such as NSAID so that the medicine can act directly on a diseased area without passing through gastrointestinal tract or mucosa. The S/O type external preparation external preparation excellent in percutaneous absorbability of the present invention comprises a medicine-containing complex dissolved or dispersed in an oil phase, wherein the complex contains a hydrophilic medicine covered with a surfactant and is in a form of a solid.
摘要:
The present invention provides a pharmaceutical preparation that significantly reduces leakage of a low-molecule medicine in a strong acidic environment, while allowing release of the low-molecule medicine in the enteric canal or the like which is in a weak acidic to neutral environment. The S/O type pharmaceutical preparation of the present invention is characterized in comprising a medicine-containing complex dissolved or dispersed in an oil phase, wherein the complex contains a mixture and a surfactant, the mixture is covered by the surfactant, and the mixture contains a hydrophilic low molecule medicine, and a hydrophilic medicine-leakage-suppressive protein and/or a medicine-leakage-suppressive polysaccharide.
摘要:
The present invention provides a substrate of TGase represented by (fluorescent group)-(linker)-(a portion containing a Gln residue capable of recognition by transglutaminase (TGase))-R, wherein the fluorescent group is fluorescein isothiocyanate (FITC), Texas Red (TE) or dansyl (Dns) or a group derived therefrom; the linker is a group represented by —NH—(CH2)n—CO— (n is an integer of 1 to 6); the portion containing a Gln residue capable of recognition by TGase is a group derived from a peptide selected from among QG and the like; and R is a hydroxyl group, or biotin, nucleic acid, azide, alkyne, maleimide or cyclopentadiene, or a group derived therefrom.
摘要:
An object of the present invention is to provide a drug delivery carrier that is free from the drug leakage problem and has an easily controllable particle size, and that can be used to deliver water-soluble drugs such as genes and proteins in a wide range of applications, including delivery of water-soluble drugs that do not have high anionic properties, and also can be used as a non-viral gene vector. The invention also provides a process for production of such drug delivery carriers. The drug delivery carrier of the present invention includes a water-soluble drug double-coated with two types of inner and outer surfactants 1 and 2.
摘要:
An object of the present invention is to provide a drug delivery carrier that is free from the drug leakage problem and has an easily controllable particle size, and that can be used to deliver water-soluble drugs such as genes and proteins in a wide range of applications, including delivery of water-soluble drugs that do not have high anionic properties, and also can be used as a non-viral gene vector. The invention also provides a process for production of such drug delivery carriers. The drug delivery carrier of the present invention includes a water-soluble drug double-coated with two types of inner and outer surfactants 1 and 2.
摘要:
A substrate for the immobilization of proteins is made by treating a carrier with an amino group-containing silicon compound represented by the following general formula: (RO)3Si—(CH2)k—(C6H4)1—(CH2)m—(NHCH2CH2)n—NH2 (wherein R is an alkyl group, and k is 1, 2, 3 . . . , l is 0, 1, 2, 3 . . . , m is 0, 1, 2, 3 . . . , and n is 1, 2, 3 . . . ).
摘要:
It is an object of the present invention to provide a cosmetic or external skin preparation that has an improved feel in use, e.g., excellent stretching on the skin surface, excellent permeation into the skin, and no stickiness, or crinkles. A cosmetic or an external skin preparation, and a medical instrument, comprising at least one lipid peptide-based gelator that contains a low-molecular lipid peptide of Formula (1): (where R1 to R3 are independently an organic group) or a pharmaceutically usable salt thereof.
摘要:
The vehicle-use electricity management system includes an electricity demand detection means to detect electricity consumed by electrical loads, and an electricity price information generation means to generate electricity price information indicative of a price of electricity supplied to the electrical loads based on the electricity demand. At least one of the electrical loads includes an electricity consumption ability determination means to determine whether electricity supplied to the own electrical load can be consumed unconditionally based on comparison between the electricity price information received from the electricity price information generation means and electricity consumption ability information stored in the own electrical load, and an electricity consumption control means to control an amount of electricity consumed by the own electrical load based on a determination result made by the electricity consumption ability determination means.
摘要:
There is provided an apparatus for controlling an electric compressor, which can actuate the electric compressor rapidly through a simpler and lower-cost configuration while achieving reduction in weight, cost, and assembling time of the electric compressor. In the case where a pressure difference between the inlet side and the outlet side of the compressor body is present when a motor of the electric compressor is actuated, the motor is actuated at a number of revolutions lower than that in the normal mode. Thereby, even if a refrigerant has been liquefied on the outlet side of the compressor body, for example, the motor can be actuated by performing such action as to push out the liquefied refrigerant. In this case, the number of revolutions of the motor is increased by being changed stepwise or linearly, by which the number of revolutions of the motor is caused to reach a required number of revolutions as early as possible while surely performing the actuation.